心力衰竭-话题@MedSci

#心力衰竭#

364篇内容 | 16667人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=957904, encodeId=c2af95e904c6, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>规范心衰治疗, objectTitle=心力衰竭, objectType=topic, longId=50884, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779297034_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=128, createdTime=2021-04-17, rootId=0, userName=1765482366, userId=135b2951405, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=880718, encodeId=c6a1880e183d, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>有可能成为心衰三驾马车：ARNI，SGLT2i，和GCa, objectTitle=Vericiguat有望在中国获得批准，用于治疗慢性心衰, objectType=article, longId=200045, objectId=1c8f200045f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020829/1598710365133_5295902.jpeg, objectUrl=/article/show_article.do?id=1c8f200045f3, replyNumber=3, likeNumber=303, createdTime=2020-08-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8f200045f3, moduleTitle=Vericiguat有望在中国获得批准，用于治疗慢性心衰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c8f200045f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=949375, encodeId=46b79493e52f, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>注重基础管理。, objectTitle=心力衰竭, objectType=topic, longId=50884, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779297034_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=106, createdTime=2021-03-18, rootId=0, userName=言西早, userId=13511650672, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=946639, encodeId=90f19466398e, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>重走长征路, objectTitle=心力衰竭, objectType=topic, longId=50884, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779297034_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=98, createdTime=2021-03-09, rootId=0, userName=易水河, userId=66771693911, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=946083, encodeId=b5cc94608389, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>强心固本, objectTitle=心力衰竭, objectType=topic, longId=50884, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779297034_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=101, createdTime=2021-03-07, rootId=0, userName=易水河, userId=66771693911, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=886429, encodeId=aa4788642915, content=<a href='/topic/show?id=d90393941be' target=_blank style='color:#2F92EE;'>#达格列净#</a>治疗<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>与利尿剂无关, objectTitle=Circulation：采用达格列净治疗心衰患者时，是否需要考虑有无使用利尿剂及其剂量？, objectType=article, longId=200891, objectId=1acf20089194, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020918/1600408928821_2110107.png, objectUrl=/article/show_article.do?id=1acf20089194, replyNumber=1, likeNumber=342, createdTime=2020-09-18, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1acf20089194, moduleTitle=Circulation：采用达格列净治疗心衰患者时，是否需要考虑有无使用利尿剂及其剂量？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1acf20089194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916583, encodeId=b35191658349, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>, objectTitle=NEJM：Omecamtiv mecarbil用于治疗射血分数降低的心力衰竭患者, objectType=article, longId=205729, objectId=ef5c205e29f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021113/1610545220425_1739456.jpg, objectUrl=/article/show_article.do?id=ef5c205e29f7, replyNumber=0, likeNumber=306, createdTime=2021-01-14, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef5c205e29f7, moduleTitle=NEJM：Omecamtiv mecarbil用于治疗射血分数降低的心力衰竭患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef5c205e29f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=915022, encodeId=4a41915022cf, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>, objectTitle=Heart：重新评价NYHA I级和II级心力衰竭, objectType=article, longId=205273, objectId=f1682052e3e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/15472823_s.jpg, objectUrl=/article/show_article.do?id=f1682052e3e2, replyNumber=0, likeNumber=308, createdTime=2021-01-09, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1682052e3e2, moduleTitle=Heart：重新评价NYHA I级和II级心力衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1682052e3e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=886269, encodeId=02bf886269d0, content=<a href='/topic/show?id=a1be1622242' target=_blank style='color:#2F92EE;'>#SGLT-2抑制剂#</a>均具有控制<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>的作用！, objectTitle=Circulation：依帕列净治疗心力衰竭：利尿和心肾效应, objectType=article, longId=200860, objectId=3403200860e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020917/1600352961221_2467676.JPG, objectUrl=/article/show_article.do?id=3403200860e5, replyNumber=0, likeNumber=294, createdTime=2020-09-18, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3403200860e5, moduleTitle=Circulation：依帕列净治疗心力衰竭：利尿和心肾效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3403200860e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=805552, encodeId=ed2b8055528f, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>这个统计分析比较有意思，他比较14天和30天获益的差别，发现30天获益更多。 , objectTitle=Am J Med：SOLVD试验——慢性心力衰竭患者服用依那普利起始剂量的早期效果, objectType=article, longId=198487, objectId=bf3c19848ef9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/147963-medical-pills-capsules.jpg, objectUrl=/article/show_article.do?id=bf3c19848ef9, replyNumber=0, likeNumber=220, createdTime=2020-08-01, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf3c19848ef9, moduleTitle=Am J Med：SOLVD试验——慢性心力衰竭患者服用依那普利起始剂量的早期效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf3c19848ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803613, encodeId=a1a280361329, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>视频课程，很好👍👍, objectTitle=罗素新：顽固性心力衰竭的诊治, objectType=video, longId=4255, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://medsci-video.oss-cn-shanghai.aliyuncs.com/upload/content/day_181105/big/201811052222453745.png, objectUrl=null, replyNumber=0, likeNumber=132, createdTime=2020-07-21, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac79214255cae, moduleTitle=罗素新：顽固性心力衰竭的诊治, moduleType=video, hrefUrl=)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601707, encodeId=2d7b601e07f4, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>SGLT2i与诺欣妥强強联合, objectTitle=OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光, objectType=article, longId=195380, objectId=e206195380ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200604/24706ed33b4e48da9c6ca8556dabda24.jpg, objectUrl=/article/show_article.do?id=e206195380ca, replyNumber=0, likeNumber=237, createdTime=2020-06-07, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e206195380ca, moduleTitle=OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e206195380ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601570, encodeId=a0946015e00a, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>BNP, objectTitle=心力衰竭生物标志物中国专家共识, objectType=guider, longId=11782, objectId=72eb01c00191a359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=72eb01c00191a359, replyNumber=0, likeNumber=182, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72eb01c00191a359, moduleTitle=心力衰竭生物标志物中国专家共识, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=72eb01c00191a359)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

让心衰不再，让心脏回归正常

2020-05-29

1765482366

#心力衰竭#规范心衰治疗

2021-04-17

lovetcm

#心力衰竭#有可能成为心衰三驾马车：ARNI，SGLT2i，和GCa

Vericiguat有望在中国获得批准，用于治疗慢性心衰

2020-08-29

言西早

#心力衰竭#注重基础管理。

2021-03-18

易水河

#心力衰竭#重走长征路

2021-03-09

易水河

#心力衰竭#强心固本

2021-03-07

lovetcm

#达格列净#治疗#心力衰竭#与利尿剂无关

Circulation：采用达格列净治疗心衰患者时，是否需要考虑有无使用利尿剂及其剂量？

2020-09-18

zb1235672

#心力衰竭#

NEJM：Omecamtiv mecarbil用于治疗射血分数降低的心力衰竭患者

2021-01-14

zb1235672

#心力衰竭#

Heart：重新评价NYHA I级和II级心力衰竭

2021-01-09

lovetcm

#SGLT-2抑制剂#均具有控制#心力衰竭#的作用！

Circulation：依帕列净治疗心力衰竭：利尿和心肾效应

2020-09-18

lovetcm

#心力衰竭#这个统计分析比较有意思，他比较14天和30天获益的差别，发现30天获益更多。

Am J Med：SOLVD试验——慢性心力衰竭患者服用依那普利起始剂量的早期效果

2020-08-01

lovetcm

#心力衰竭#视频课程，很好👍👍

罗素新：顽固性心力衰竭的诊治

2020-07-21

lovetcm

#心力衰竭#SGLT2i与诺欣妥强強联合

OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光

2020-06-07

lovetcm

#心力衰竭#BNP

心力衰竭生物标志物中国专家共识

2020-06-06